Table 1.
Response | Main findings | Cell type | Coating and plate | Stretch machine | Stretch pattern | Stretch duration | Serum | Reference |
---|---|---|---|---|---|---|---|---|
Increased proliferation | Small proliferation increase with stretch | NRVF | Collagen-coated silicone membrane | Homemade stretch device | 20% uniaxial | 24 h | Serum-free | Sadoshima et al., (1992)132 |
Proliferation increased by stretch | NRVF | Collagen-coated silicone membrane plate | Flexcell∗ | 1-Hz, 30% | 24 h and 48 h | Serum-free | Cao and Gardner, (1995)91 | |
Increased fibroblast proliferation with low stretch (2%) for 24 or 72 h. In high-stretch conditions (8%), increased only at 24 h | Human atrial fibroblast | Fibronectin | Homemade stretch device | 1-Hz, 2% or 8% uniaxial | 24 h and 72 h | NS | Ugolini et al., (2016)92 | |
Increase in proliferation of stretched fibroblasts seeded on low stiffness substrate (3 kPa), and in fibroblasts cultured with medium from stretched cardiomyocytes | Adult mouse ventricular fibroblast | Collagen I-coated polyacrylamide gel on PDMS membrane | Homemade stretch device | Static, 3% or 6% uniaxial | 24 h and 48 h | 10%-FBS | Herum et al., (2017)90 | |
Increased proliferation with low stretch+hypoxia (1%-O2), no stretch+hypoxia and low stretch+physoxia (6%-O2) | Human ventricular fibroblast | Fibronectin | Homemade stretch device | 1-Hz, 2% or 8% uniaxial | 24 h | NS | Ugolini et al., (2017)87 | |
No change or decreased proliferation | Decreased proliferation after 12-h stretch in 10% FBS-containing medium. No change with longer stretch or 1% FBS | Foetal RCF | Elastin-coated plate | Flexercell∗ FX-2000 | 1.5-Hz, 20% equibiaxial | 8–88 h | 0%, 1%, or 10% FBS | Butt and Bishop, (1997)89 |
Decreased proliferation after stretch. Fibroblasts stopped at G2/M; increased p21, decreased cyclin-B1 | Neonatal RCF | Collagen-coated silicone membrane | Modified from Lee et al., 1996131 | 20% sustained stretch | 1, 4, 12, 24 h | 10% FBS | Liao et al., (2004)88 | |
Decreased proliferation by 12-h stretch regardless of ECM substrate. Decrease most marked on randomly organized collagen | Neonatal RCF | Fibronectin-, laminin-, collagen-coated and uncoated charged silicone elastic membrane | Modified from Yost et al., 2000101 | 0.08 Hz, 5% uniaxial | 12 h | 10% NBS + 5% FBS | Atance et al., (2004)86 | |
Decreased proliferation with high strain (8% stretch) for 72 h | Human atrial fibroblast | Fibronectin | Homemade stretch device | 1 Hz, 2% or 8% uniaxial | 24 h and 72 h | NS | Ugolini et al., (2016)92 | |
Decreased proliferation on high substrate stiffness (8 kPa) | Adult mouse ventricular fibroblast | Collagen I-coated polyacrylamide gel, polydimethylsiloxane membrane | Homemade stretch device | Static, 3% or 6% uniaxial | 24 h and 48 h | 10% FBS | Herum et al., (2017)90 | |
No change with no-stretch+physoxia (6%-O2) or high-strain stretch (8%)+physoxia | Human ventricular fibroblast | Fibronectin | Homemade device | 1 Hz, 2% or 8% uniaxial | 24 h | NS | Ugolini et al., (2017)87 | |
Apoptosis | No cell death or apoptosis | NRVF | Collagen I | Flexercell FX-2000 | 1 Hz, 20% equiaxial | 24, 48, 96 h | 2.5% FBS | Persoon-Rothert et al., (2002)98 |
No apoptosis | Neonatal RCF | Rat tail collagen-coated silicone membrane | Modified from Lee et al., 1996131 | 20% sustained stretch | 1, 4, 12, 24 h | 10% FBS | Liao et al., (2004)88 | |
Few apoptotic genes differentially expressed in stretched fibroblasts; >15% apoptotic genes increased in myocyte-enriched fractions | NRVF | Collagen I | Flexercell FX-2000 | 1 Hz, 20% equiaxial | 24 h | 2.5% FBS | Boerma et al., (2005)99 | |
Morphology | Cells elongated, oriented, perpendicular to the direction of stretch | Neonatal RCF | Laminin-coated silicone elastomer membranes | Homemade stretch device | 10 cycles/min, 10% uniaxial stretch | 72 h | NS | Terracio et al., (1988)78 |
Cells rotated to align more perpendicular to the direction of stretch | Neonatal RCF | Aligned collagen-coated silicone membrane | Homemade stretch device | 3%, 6%, 12% uniaxial; 0, 5, 10 cycles/min | 12 h | 5% FBS + 10% NBS | Yost et al., (2000)101 | |
Cells surface area increased on all ECM substrates | Neonatal RCF | Fibronectin-, laminin-, collagen-coated; uncoated charged silicone elastic membrane | Modified from Yost et al., 2000101 | 0.08 Hz, 5% uniaxial | 1, 5, and 10 min | 10% NBS + 5% FBS | Atance et al., (2004)86 | |
Cell margin ruffling, disorganization of long actin stress fibres, retraction of cortical cytoplasm. Effects that are immediate, persisted over time | Neonatal RCF | Laminin-coated silastic membrane | Modified from MacKenna et al., 200076 | 5% equibiaxial | 0, 1.25, 2.5, 5, 10, 20, and 40 min | 10% FBS + 5% NBS | Fuseler et al., (2007)100 |
ECM, extracellular matrix; FBS, foetal bovine serum; NBS, newborn bovine serum; NRVF, neonatal rat ventricular fibroblasts; NS, not stated; RCF, rat cardiac fibroblasts.
Please note that this company has used both Flexcell and Flexercell as names; we have retained the usage in each paper cited.